Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
Hepatology2013Vol. 58(6), pp. 1930–1940
Citations Over TimeTop 1% of 2013 papers
Mazen Noureddin, Jessica Lam, Michael R. Peterson, Michael S. Middleton, Gavin Hamilton, Thuy‐Anh Le, Ricki Bettencourt, Chris Changchien, David A. Brenner, Claude B. Sirlin, Rohit Loomba
Abstract
In this longitudinal study, MRI-PDFF correlated well with MRS-PDFF and was more sensitive than the histology-determined steatosis grade in quantifying increases or decreases in the liver fat content. Therefore, it could be used to quantify changes in liver fat in future clinical trials.
Related Papers
- → Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?(2016)269 cited
- → Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis(2009)266 cited
- → Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease(2019)32 cited
- → Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives(2015)4 cited
- → Relationship of serum vaspin, nafld fibrosis score to ultrasonographic detection and quantification of steatosis in nonalcoholic fatty liver disease patients(2021)1 cited